A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Parkinson's disease (PD) is an advanced neurodegenerative disease (NDD) caused by the degeneration of dopaminergic neurons (DNs) in the substantia nigra (SN). As PD is an age-related disorder, the majority of PD patients are associated with musculoskeletal disorders with prolonged use of analgesic and anti-inflammatory agents, such as non-steroidal anti-inflammatory drugs (NSAIDs). Therefore, NSAIDs can affect PD neuropathology in different ways. Thus, the objective of the present narrative review was to clarify the potential role of NSAIDs in PD according to the assorted view of preponderance. Inhibition of neuroinflammation and modulation of immune response by NSAIDs could be an effective way in preventing the development of NDD. NSAIDs affect PD neuropathology in different manners could be beneficial or detrimental effects. Inhibition of cyclooxygenase 2 (COX2) by NSAIDs may prevent the development of PD. NSAIDs afforded a neuroprotective role against the development and progression of PD neuropathology through the modulation of neuroinflammation. Though, NSAIDs may lead to neutral or harmful effects by inhibiting neuroprotective prostacyclin (PGI2) and accentuation of pro-inflammatory leukotrienes (LTs). In conclusion, there is still a potential conflict regarding the effect of NSAIDs on PD neuropathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NSAIDs have an antagonistic effect on PD that is beneficial through the modulation of neuroinflammation but detrimental through the inhibition of neuroprotective prostacyclin (PGI2) and accentuation of proinflammatory leukotrienes (LTs).484”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [484]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 184 · Cited by 47
Research works printed but not linked: 6
- Al-kuraishy HM, Al-windy SA (2013) Experimental antibacterial activity of selective cyclooxygenase antagonist. Int J Pharm Chem Biol Sci 3(3):692–699
- Batiha GE-S, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E (2022) SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close. Inflammopharmacology 29:1–20
- Ling Q-l, Murdoch E, Ruan K-H (2016) How can we address the controversies surrounding the use of NSAIDS in neurodegeneration? Future Sci 8:1153–1155
- Ramazani E, Tayarani-Najaran Z, Fereidoni M (2019) Celecoxib, indomethacin, and ibuprofen prevent 6-hydroxydopamine-induced PC12 cell death through the inhibition of NFκB and SAPK/JNK pathways. J Basic Med Sci 22:477
- Schwartz M, Ziv Y (2008) Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer’s disease? Trends Pharmacol. Sci 29:287–293
- Zarghi A, Arfaei S (2011) Selective COX-2 inhibitors: a review of their structure-activity relationships. Iranian J Pharm Res 10:655
Metadata
- Authors
- Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Saad, H. M., & Batiha, G. E.-S.
- Affiliations
- Shaqra University (SA)
- Mustansiriyah University (IQ)
- Matrouh University (EG)
- Damanhour University (EG)
- Corresponding author
- Alrouji, Mohammed
- Al-Kuraishy, Hayder M.
- Al-Gareeb, Ali I.
- Saad, Hebatallah M.
- Batiha, Gaber El-Saber
- ORCID
- Venue
- Inflammopharmacology
- Published
- 2023-03-24
- Volume
- 31
- Issue
- 2
- Pages
- 673-688
- ISSN
- 0925-4692 (ISSN-L)
- 1568-5608
- OpenAlex
- W4360809405
- Cited by
- 47
- References
- 184
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 15 · 2023: 7
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Inflammopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Parkinson's disease, nonsteroidal anti-inflammatory drugs, neuroinflammation, COX-2 inhibition, prostacyclin, leukotrienes, neuroprotection, dopaminergic neuron loss, substantia nigra, neurodegenerative diseases, musculoskeletal disorders
- MeSH terms
- Neuroinflammatory Diseases, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Humans, Parkinson Disease, Neuroprotective Agents, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects. https://app.cochat.ai/papers/10.1007/s10787-023-01192-2
- The paper
- Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Saad, H. M., & Batiha, G. E.-S. (2023). A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects. Inflammopharmacology. https://doi.org/10.1007/s10787-023-01192-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.